Pharmacolog AB and HelioMetrics® Partner to Provide Critcal Drug Diversion Solutions
June 13 2018 - 1:00PM
Business Wire
Collaboration Assures Essential Patient Safety
with Behavioral Analytics & Prevention of Drug Mismanagement as
Leading Swedish Innovator Expands into the United States
Pharmacolog AB and HelioMetrics today announced a new
partnership that will deliver solutions designed to stop drug
diversion and provide safe administration of IV medications for
hospitals and pharmacies in the United States. Headquartered in
Sweden, this partnership will help Pharmacolog expand into the U.S.
market resulting in comprehensive drug diversion programs with
strategies to guarantee patient safety.
HelioMetrics is the industry’s leading drug diversion platform
that provides advanced data analytics that alarm against suspicious
diversion behavior and deviating drug prescribing patterns.
Pharmacolog’s DrugLog® is used to quickly screen the returns of
opioids from the surgical ward and can detect if the narcotic
substance has been replaced or tampered with. The measurement data
from DrugLog is then collected by the data analytics software
resulting in an accurate summary of the drug’s lifecycle.
“We are extremely happy to join forces with HelioMetrics,” said
Mats H�gberg, CEO, Pharmacolog AB. “Their experience in drug
diversion is very valuable for us as we enter the U.S. market.
There are several companies developing data analytics software for
drug diversion, but HelioMetrics is the most reliable and
comprehensive platform on the market.”
“Our respective value propositions complement each other in the
effort to prevent drug diversion,” said Jeremy Wunsch, CEO,
HelioMetrics, Inc. “Pharmacolog’s DrugLog device can provide
crucial data when screening the returned narcotic substances, data
that - when processed into HelioMetrics advanced drug diversion
analytics software - becomes vital information in the efforts to
prevent illicit use of controlled drugs in healthcare.”
About Pharmacolog ABPharmacolog specializes in efficient
solutions to prevent medication errors and to simplify the
reconstitution and compounding process of medical drugs. Its
advanced DrugLog® device can determine a drugs identity and
concentration in seconds and therefore offers a unique method for
quick and effective screening in a Drug Diversion program.
Headquartered in Uppsala Sweden, please visit www.pharmacolog.com
for more information.
About HelioMetrics®HelioMetrics is the industry’s
leading advanced drug diversion software
platform. Its proprietary Diversion Triangulation™
methodology, along with behavior analytics, gives
healthcare systems and pharmacies a closed loop process
for the precise monitoring, detection and investigation of
drug diversion while validating compliance to medication handling
policies. Headquartered in Minneapolis, Minn., please
visit heliometrics.net for more information.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180613005945/en/
HelioMetricsCherie
Mitchellcmitchell@heliometrics.netorPharmacolog ABMats
H�gbergmats.hogberg@pharmacolog.se